GlassScriptPhysician profile
Saron Belay
NPI 1306432653
$4,676.43
in general payments reported to CMS, 2019-2025
32 companies · $652 in 2025
The $652 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $871 · 2022: $1,274 · 2023: $1,184 · 2024: $695 · 2025: $652.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,531.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $639.07 | 2021-2023 | Urolift |
| Janssen Biotech, INC. | $531.76 | 2022-2025 | Erleada, Carvykti, Rybrevant |
| Astellas Pharma US INC | $497.91 | 2021-2025 | Xtandi, Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $384.74 | 2023-2025 | Gemtesa, Orgovyx |
| Urovant Sciences INC | $367.88 | 2021-2022 | |
| Medtronic, INC. | $367.72 | 2021-2023 | Interstim |
| Tolmar, INC. | $255.71 | 2023-2025 | Jatenzo, Eligard |
| Bayer Healthcare Pharmaceuticals INC. | $230.68 | 2024-2025 | |
| Endo USA, INC. | $197.20 | 2024-2025 | Xiaflex, Aveed, Edex |
| Abbvie INC. | $126.69 | 2021-2025 | |
| Tolmar Pharmaceuticals, INC. | $118.74 | 2021-2022 | |
| Boston Scientific Corporation | $115.84 | 2022-2025 | Spaceoar System, Axonics |
| Pfizer INC. | $95.31 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $90.24 | 2021-2023 | Keytruda, Lynparza |
| Endo Pharmaceuticals INC. | $90.22 | 2023-2024 | Aveed, Xiaflex, Edex |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $87.95 | 2025 | |
| Clarus Therapeutics INC. | $68.60 | 2021 | |
| Olympus America INC. | $57.04 | 2021-2025 | Itind System |
| Blue Earth Diagnostics | $54.44 | 2022-2023 | |
| Ferring Pharmaceuticals INC. | $39.12 | 2024-2025 | Adstiladrin |
| Acerus Pharmaceuticals Corporation | $36.99 | 2021-2022 | |
| Accord Healthcare, INC. | $34.34 | 2022-2023 | |
| 180 Medical, INC. | $28.44 | 2023-2024 | Gentlecath |
| Coloplast Corp | $24.56 | 2023 | Speedicath |
| Telix Pharmaceuticals | $19.98 | 2024 | Illuccix |
| Allergan, INC. | $17.94 | 2021 | |
| Valencia Technologies Corporation | $17.88 | 2023 | Ecoin Device Kit |
| Photocure INC | $16.91 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.74 | 2022 | |
| Axonics, INC. | $16.48 | 2022 | |
| Myriad Genetic Laboratories, INC. | $15.76 | 2021 | |
| Mission Pharmacal Company | $13.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saron Belay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.